Original-Research: Reply S.p.A. - from GBC AG
Classification of GBC AG to Reply S.p.A.
Dear Investors, The 'GBC Italian Champions Study 2026' contains assessments of the following companies: Avio S.p.A. (ISIN: IT0005119810) Casta Diva Group S.p.A. (ISIN: IT0005003782) Cembre S.p.A. (ISIN: IT0001128047) Fine Foods & Pharmaceuticals N.T.M. S.p.A. (ISIN: IT0005215329) Franchetti S.p.A. (ISIN: IT0005508574) Lindbergh S.p.A. (ISIN: IT0005469272) Lottomatica Group S.p.A. (ISIN: IT0005541336) Otofarma S.p.A. (ISIN: IT0005663361) Reply S.p.A. (ISIN: IT0005282865) Sanlorenzo S.p.A. (ISIN: IT0003549422) Siav S.p.A. (ISIN: IT0005504128) Somec S.p.A. (ISIN: IT0005329815) We hope you enjoy reading this study and wish you every success with your investments. Cosmin Filker Deputy Chief Analyst You can download the research here: 20261109_Italian_Champions_engl Contact for questions: GBC AG Halderstraße 27 86150 Augsburg 0821 / 241133 0 research@gbc-ag.de ++++++++++++++++ Disclosure of potential conflicts of interest in accordance with Section 85 WpHG and Art. 20 MAR The following potential conflict of interest exists at the company analysed above: (see individual studies); a catalogue of potential conflicts of interest can be found at: https://www.gbc-ag.de/de/Offenlegung +++++++++++++++ Editorial deadline: 03/11/2026 Date and time of completion of the study: 09/11/2026 (10:09 a.m.) Date and time of first dissemination of the study: 09/11/2026 (1:00 p.m.) The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. | ||||||||||||||||||
2430858 09.11.2026 CET/CEST




